Malignant behaviors and immune response in melanoma: Epstein-Barr virus induced gene 3 as a therapeutic target based on an in-vitro exploration
- PMID: 39726752
- PMCID: PMC11670768
- DOI: 10.7717/peerj.18730
Malignant behaviors and immune response in melanoma: Epstein-Barr virus induced gene 3 as a therapeutic target based on an in-vitro exploration
Abstract
Background: Epstein-Barr virus induced gene 3 (EBI3), a member of the IL-12 family, is known to be involved in malignant progression in a variety of cancers, but its role in melanoma is unclear. The aim of this study was to explore the effects of EBI3 on the malignant phenotype melanoma to reveal its potential as a therapeutic target.
Methods: In this study, we used bioinformatics to analyze the expression of EBI3 in pan-cancer and verified its expression level in melanoma cells by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Subsequently, the effects of EBI3 knockdown on cell proliferation, migration and invasion were detected using the Cell Counting Kit-8 (CCK-8) and Transwell assays. Changes in immune-related cytokines were detected by ELISA, and macrophage polarization was observed using immunofluorescence. Finally, the phosphorylation levels of signaling pathways such as Smad3, STAT6 and cGAS-STING were analyzed by Western blot.
Results: EBI3 was evidently highly-expressed in melanoma, and silencing of EBI3 could visibly suppress the survival and migration/invasion of melanoma cells, concurrent with the increased levels of BAX and CDH1 and the decreased expressions of BCL2 and CDH2. Meanwhile, EBI3 knockdown diminished the phosphorylation levels of both Smad3 and STAT6 and the levels of immune response-relevant cytokines in melanoma cells, while aggravating the macrophage M1 polarization and the expression of cGAS, p-STING and p-IRE1 α in THP-1 monocyte-derived macrophages co-cultured with EBI3-silenced melanoma cells.
Conclusion: This study filled the blank on the involvement of EBI3 in melanoma, hinting the possibility of controlling EBI3 as a therapeutic strategy in the management of melanoma.
Keywords: Epstein-Barr Virus Induced Gene 3; Immune response; Macrophage; Malignant behaviors; Melanoma.
© 2024 Zhang et al.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures






Similar articles
-
Epstein-Barr virus-induced gene 3 (EBI3) can mediate IL-6 trans-signaling.J Biol Chem. 2017 Apr 21;292(16):6644-6656. doi: 10.1074/jbc.M116.762021. Epub 2017 Mar 9. J Biol Chem. 2017. PMID: 28280243 Free PMC article.
-
Epstein-Barr Virus-induced Gene 3 as a Novel Biomarker in Metastatic Melanoma With Infiltrating CD8+ T Cells: A Study Based on The Cancer Genome Atlas (TCGA).Anticancer Res. 2022 Jan;42(1):511-517. doi: 10.21873/anticanres.15509. Anticancer Res. 2022. PMID: 34969761
-
Epstein-Barr Virus-Induced Gene 3 (EBI3) Blocking Leads to Induce Antitumor Cytotoxic T Lymphocyte Response and Suppress Tumor Growth in Colorectal Cancer by Bidirectional Reciprocal-Regulation STAT3 Signaling Pathway.Mediators Inflamm. 2016;2016:3214105. doi: 10.1155/2016/3214105. Epub 2016 May 10. Mediators Inflamm. 2016. PMID: 27247488 Free PMC article.
-
Multiple pro-tumorigenic functions of the human minor Histocompatibility Antigen-1 (HA-1) in melanoma progression.J Dermatol Sci. 2017 Nov;88(2):216-224. doi: 10.1016/j.jdermsci.2017.07.004. Epub 2017 Jul 8. J Dermatol Sci. 2017. PMID: 28939173
-
A Chaperone-Like Role for EBI3 in Collaboration With Calnexin Under Inflammatory Conditions.Front Immunol. 2021 Sep 17;12:757669. doi: 10.3389/fimmu.2021.757669. eCollection 2021. Front Immunol. 2021. PMID: 34603342 Free PMC article. Review.
References
-
- Amuthalakshmi S, Sindhuja S, Nalini CN. A review on PCR and POC-PCR—a boon in the diagnosis of COVID-19. Current Pharmaceutical Analysis. 2022;18(8):745–764. doi: 10.2174/1573412918666220509032754. - DOI
-
- Azumi J, Takeda T, Shimada Y, Zhuang T, Tokuji Y, Sakamoto N, Aso H, Nakamura T. Organogermanium THGP induces differentiation into M1 macrophages and suppresses the proliferation of melanoma cells via phagocytosis. International Journal of Molecular Sciences. 2023;24(3):1885. doi: 10.3390/ijms24031885. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous